Grain‐sized moxibustion promotes NK cell antitumour immunity by inhibiting adrenergic signalling in non–small cell lung cancer

Lung cancer is the leading cause of cancer‐related death worldwide, and non–small cell lung cancer (NSCLC) accounts for 85% of lung cancer diagnoses. As an ancient therapy, moxibustion has been used to treat cancer‐related symptoms in clinical practice. However, its antitumour effect on NSCLC remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Dan, Shen, Weiming, Gong, Chenyuan, Fang, Cheng, Yao, Chao, Zhu, Xiaowen, Wang, Lixin, Zhao, Chen, Zhu, Shiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957214/
https://www.ncbi.nlm.nih.gov/pubmed/33506637
http://dx.doi.org/10.1111/jcmm.16320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957214/
https://www.ncbi.nlm.nih.gov/pubmed/33506637
http://dx.doi.org/10.1111/jcmm.16320

Ejemplares similares